NL-OMON49286已完成不适用
ATTR amyloidosis in patients with heart failure with preserved ejection fraction and a cardiac implantable electronic device - AMYL-VIP-Device study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Heart failure, NYHA 2 or 3.
- •LVEF > 40%
- •NT-proBNP >400 ng/L sinus rhythm; > 1200 ng/L atrial fibrillation
排除标准
- •Unwilling or unable to sign informed consent.
- •Life expectancy < 1 year.
- •Signficant coronary artery disease or myocardial infarction < 3 months
研究者
相似试验
招募中
不适用
ATTR amyloidosis in patients undergoing transcatheter aortic valve replacement: from prevalence to hemodynamic consequence.AmyloidosisNL-OMON55157niversitair Medisch Centrum Groningen340
进行中（未招募）
不适用
Myocardial Effects in Patients With ATTRv With Polyneuropathy Treated With Patisiran or VutrisiranTransthyretin AmyloidosisAmyloidosis, HereditaryNCT05873868Rennes University Hospital20
Unknown
不适用
Noninvasive Assessment of Myocardial Stiffness by 2D-SWE Ultrasound Technique (Bidimensional Shear Wave Elastography) in Patients With Transthyretin AmyloidosisAmyloidosisNCT04456582Fábio Fernandes60
尚未招募
Unknown
Screening for cardiac amyloidosis in patients with newly identified conduction diseaseCardiac amylodiosisCardiovascular - Other cardiovascular diseasesACTRN12624000520538Box Hill Hospital220
进行中（未招募）
不适用
Amyloidosis TTR Flow Reserve EvaluationAmyloid CardiomyopathyNCT05103943Centre Hospitalier Régional d'Orléans50